What Autoimmune Diseases Affect Lymph Nodes?

A surprisingly wide range of autoimmune diseases can cause swollen lymph nodes, a finding doctors call lymphadenopathy. Lupus, rheumatoid arthritis, Sjögren’s syndrome, sarcoidosis, and IgG4-related disease are among the most common culprits, but the list extends to rarer conditions like autoimmune lymphoproliferative syndrome and even organ-specific diseases such as Hashimoto’s thyroiditis. What makes autoimmune lymphadenopathy tricky is that swollen nodes can look and feel a lot like infection or lymphoma, which means it often triggers anxiety and invasive testing before the true cause is identified.

Systemic Lupus Erythematosus

Lupus is probably the autoimmune disease most strongly linked to swollen lymph nodes. Estimates of how often it happens vary widely, with reported prevalence ranging from about 12% to 59% of people with lupus depending on the study and how carefully nodes are checked.¹ Cervical nodes in the neck are the most frequently affected, followed by mesenteric nodes in the abdomen, then axillary and inguinal nodes.¹ Generalized lymphadenopathy in lupus tends to track with more active disease and the presence of anti-double-stranded DNA antibodies.²

Despite being common, lymphadenopathy is not part of the standard diagnostic criteria for lupus, which means it often catches clinicians off guard.³ In some cases, swollen lymph nodes are actually the first thing that brings a person to medical attention before any other lupus symptoms appear, though that scenario is rare.⁴ When a biopsy is performed on lupus-related nodes, the tissue often shows a pattern of paracortical hyperplasia with prominent blood vessel growth, many follicles, and a mix of small T-cells and plasma cells. This pattern can look disturbingly similar to certain lymphomas, and pathologists have to be careful not to overdiagnose malignancy.⁵

Rheumatoid Arthritis

Swollen lymph nodes in rheumatoid arthritis are more common than many people realize. Studies have found lymphadenopathy in up to 82% of RA patients, though the swelling is usually localized rather than widespread.² The nodes that enlarge tend to be the ones closest to actively inflamed joints. If your wrists and hands are the main problem, for instance, the axillary (armpit) nodes are the ones most likely to swell. The size of the nodes has also been linked to how many tender and swollen joints a person has.

Under a microscope, RA lymphadenopathy looks different from what you see in lupus. It features prominent follicular hyperplasia, sometimes with neutrophils infiltrating the sinuses and interfollicular areas.⁶ Interestingly, mediastinal lymph node enlargement in RA has been linked to RA-related interstitial lung disease, which reinforces the idea that the nodes draining a particular region swell in proportion to the inflammation in that region.²

There is also a growing understanding of why RA lymph nodes behave this way at a cellular level. Research suggests that the stromal cells inside RA lymph nodes may present self-antigens in ways that activate immune cells rather than teaching them tolerance, essentially turning the lymph node from a peacekeeper into an instigator.⁷

Sjögren’s Syndrome and the Lymphoma Question

Sjögren’s syndrome causes dry eyes and dry mouth because the immune system attacks moisture-producing glands. Lymph node swelling and salivary gland enlargement are common features, but they carry a specific concern that sets Sjögren’s apart from other autoimmune diseases: a meaningfully elevated risk of lymphoma. The lymphoma type most closely associated with Sjögren’s is mucosa-associated lymphoid tissue (MALT) lymphoma, which tends to arise in the salivary glands.⁸ In one cohort of patients with primary Sjögren’s, about 11% were eventually diagnosed with lymphoma, and all of them had clinical signs at the time of diagnosis.⁸

Researchers have identified a set of independent risk factors that predict lymphoma development in Sjögren’s. These include salivary gland enlargement, lymphadenopathy, Raynaud’s phenomenon, certain autoantibodies (anti-Ro/SSA, anti-La/SSB), rheumatoid factor positivity, monoclonal gammopathy, and low complement (C4).⁹ A risk scoring system based on these factors found that patients with two or fewer risk factors had roughly a 4% chance of developing lymphoma, while those with three to six risk factors had close to a 40% probability.⁹ Additional predictors identified in the literature include skin vasculitis, peripheral neuropathy, cryoglobulinemia, and the formation of organized ectopic germinal centers within the salivary glands themselves.¹⁰

The practical takeaway for someone with Sjögren’s: not every swollen lymph node signals cancer, but new or rapidly growing nodes, especially combined with the risk factors above, warrant a conversation with your rheumatologist. The same study that reported the 11% lymphoma rate also found that routine screening ultrasounds of the neck and salivary glands in asymptomatic patients did not catch lymphomas earlier, suggesting that clinical vigilance matters more than blanket screening.⁸

Sarcoidosis

Sarcoidosis is sometimes grouped with autoimmune diseases and sometimes classified separately as a granulomatous disorder, but however you categorize it, lymph node involvement is its hallmark. Lung, mediastinal, and hilar lymph nodes are affected in around 90% of patients, and this involvement accounts for most of the disease’s morbidity and mortality.¹¹ The characteristic finding is noncaseating granulomas, clusters of immune cells that form tiny nodules without the central dead tissue you see in infections like tuberculosis.

Because sarcoidosis so heavily involves lymph nodes inside the chest, it often gets picked up incidentally on chest X-rays or CT scans done for other reasons. Confirming the diagnosis usually requires a tissue sample. One approach uses a bronchoscope with ultrasound guidance to biopsy mediastinal or hilar nodes through the airway wall. Studies show this technique identifies the telltale noncaseating granulomas in roughly 62–66% of cases, with similar success rates regardless of whether hilar or mediastinal nodes are targeted.¹²

IgG4-Related Disease

IgG4-related disease is a relatively newly recognized condition that can affect almost any organ, and lymph node swelling is one of its most frequent features. In some patients, enlarged nodes are the very first sign that something is wrong.¹³ What makes diagnosing IgG4-related lymphadenopathy especially challenging is that the biopsied nodes can take on at least five different histological patterns. A diagnosis generally requires both elevated serum IgG4 levels and specific features on biopsy, including dense infiltrates of plasma cells that stain positive for IgG4.¹³

Because IgG4-related disease can mimic lymphoma, pancreatic cancer, or other serious conditions depending on which organs are involved, biopsies from IgG4-RD patients are often initially suspected to be cancer. Awareness of this condition has grown considerably over the past decade, which has helped reduce unnecessary treatment.

Rarer Autoimmune Conditions That Involve Lymph Nodes

Several less common autoimmune and autoinflammatory diseases also cause lymph node swelling, and they are worth knowing about because they can be puzzling to diagnose.

ALPS: Autoimmune lymphoproliferative syndrome is an inherited disorder caused by mutations in the FAS signaling pathway, which normally tells immune cells when to self-destruct. When that signal fails, a distinctive population of “double-negative” T cells accumulates, leading to lymphadenopathy, an enlarged spleen, low blood cell counts, and a substantially increased lifetime risk of lymphoma.¹⁴ On biopsy, the lymph nodes in ALPS show florid paracortical expansion that can be so dramatic it gets mistaken for malignant lymphoma.¹⁵
Hashimoto’s thyroiditis: Most people associate Hashimoto’s with an underactive thyroid, not lymph node problems. Cervical lymphadenopathy has been reported in Hashimoto’s, but it is rare and can be confusing when it shifts location over time.¹⁶
Adult-onset Still’s disease: This autoinflammatory condition causes high spiking fevers, a salmon-colored rash, and joint pain. In some patients, extensive lymphadenopathy develops to the point where it raises serious concern for lymphoma.¹⁷
Multicentric Castleman disease: While Castleman disease is not a classic autoimmune condition, its idiopathic multicentric form (iMCD) can closely resemble autoimmune diseases and features widespread lymphadenopathy driven by overproduction of inflammatory signaling molecules like IL-6.¹⁸

Kikuchi-Fujimoto Disease and Its Autoimmune Overlap

Kikuchi-Fujimoto disease, also called histiocytic necrotizing lymphadenitis, deserves special mention because it sits at the intersection of mysterious lymph node disease and autoimmunity. It mainly affects young women and causes fever and tender, swollen lymph nodes, usually in the neck. It typically resolves on its own within a few months, but its microscopic appearance in biopsied nodes can closely resemble lupus lymphadenitis, and some researchers have proposed that it may be a self-limiting form of lupus.¹⁹

The overlap goes both ways. In some patients, Kikuchi-Fujimoto disease is eventually followed by a full-blown autoimmune diagnosis. A multicenter study of children with the condition found that about 1.2% went on to develop a systemic autoimmune disease such as lupus, Sjögren’s syndrome, or juvenile idiopathic arthritis, with most of those diagnoses coming within two years of the initial episode.²⁰ In other cases, lupus patients develop Kikuchi-Fujimoto disease as a complication of their existing illness.²¹ For clinicians, the practical lesson is that any young woman presenting with unexplained lymphadenopathy and fever should be evaluated for both conditions, because the biopsy findings alone may not tell them apart.

How Doctors Tell Autoimmune Lymphadenopathy from Lymphoma

This is the question that keeps both patients and doctors up at night. Swollen lymph nodes in someone with lupus, RA, Sjögren’s, or ALPS can look alarmingly similar to lymphoma under a microscope. In ALPS, for example, the paracortical expansion can be so florid that referring pathologists have suspected malignant lymphoma before additional testing ruled it out.¹⁵ In lupus lymphadenopathy, the biopsy pattern closely mimics a type of T-cell lymphoma, and distinguishing the two requires careful attention to clinical context and molecular testing rather than just morphology.⁵

Imaging can help narrow things down. PET/CT scans, which measure metabolic activity, have shown that autoimmune (reactive) lymph node enlargement tends to light up less intensely than Hodgkin lymphoma.²² One study of patients with systemic autoimmune disease who had multiple enlarged lymph nodes on PET/CT found that the majority, 18 out of 25 cases with lymphadenopathy, turned out to be reactive (benign) rather than malignant. Specific ratios of metabolic activity between bone marrow, spleen, and liver helped distinguish the small number of malignancies from the reactive majority.²³

None of this means imaging alone settles the question. A biopsy remains the gold standard when there is genuine concern about malignancy. But for patients with a known autoimmune disease who develop new lymphadenopathy, imaging patterns, blood markers, and disease activity scores together often provide enough information to determine whether a biopsy is necessary or whether the nodes are simply reflecting a flare.

How Treatment Affects Lymph Node Swelling

One of the more reassuring aspects of autoimmune lymphadenopathy is that it typically responds to the same treatments used for the underlying disease. In both lupus and rheumatoid arthritis, swollen lymph nodes tend to shrink when the disease is brought under control, particularly with corticosteroid therapy. Improvement in lymphadenopathy tends to track with improvement in joint inflammation and other disease measures.⁶

This responsiveness is actually diagnostically useful. If swollen lymph nodes shrink with anti-inflammatory treatment and return during flares, that pattern strongly suggests the nodes are autoimmune-related rather than harboring something else. Nodes that do not respond to treatment, continue to grow despite disease control, or develop asymmetrically in an unexpected location deserve more aggressive workup.

When Medications Themselves Cause Lymphadenopathy

An underappreciated wrinkle is that some drugs used to treat autoimmune disease can independently cause lymph node swelling. Methotrexate, one of the most commonly prescribed drugs for RA and lupus, has been linked to a rare condition called methotrexate-associated lymphoproliferative disorder, in which the drug itself drives abnormal lymphocyte growth. This typically resolves when methotrexate is stopped, but it can mimic lymphoma and sometimes requires biopsy to sort out. Biologics that suppress immune function, including TNF inhibitors, have also been associated with lymphadenopathy in case reports. For someone already living with an autoimmune disease, this adds another variable to the diagnostic puzzle when new swelling appears: is it the disease, a flare, an infection, a medication side effect, or something more serious?

Clinicians working with autoimmune patients generally approach new lymphadenopathy stepwise. They consider how many nodes are involved, how large they are, whether they are in a location consistent with the patient’s disease pattern, and how the nodes behave over time and in response to treatment. Rushing to biopsy every swollen node would subject patients to unnecessary procedures, while ignoring persistent or atypical adenopathy carries the risk of missing a genuine malignancy. The clinical judgment required is real and sometimes uncomfortable for everyone involved.

Why Lymph Nodes Malfunction in Autoimmune Disease

The story of autoimmune lymphadenopathy is not just about lymph nodes passively swelling in response to disease activity elsewhere. Increasingly, researchers see lymph nodes as active participants in autoimmune disease rather than innocent bystanders. Normally, lymph nodes serve as checkpoints where immune cells learn to distinguish the body’s own tissues from foreign invaders. The stromal cells lining the lymph node interior present fragments of the body’s own proteins, and immune cells that react too aggressively to those fragments are weeded out, a process called peripheral tolerance.

In RA, there is evidence that this process goes wrong. The stromal environment inside the lymph node appears to be dysregulated in ways that lead immune cells to become activated against the body’s own proteins instead of being deleted or silenced.⁷ This reframes autoimmune lymphadenopathy not as a downstream symptom but as a window into the mechanism of the disease itself. The enlarged, activated lymph node is not just reporting inflammation from somewhere else; it may be part of the machinery driving the immune attack. This idea is still being fleshed out, but it has shifted how researchers think about the relationship between lymph nodes and autoimmune disease, moving lymph nodes from the margins of the story to something closer to the center.

1
PubMed. Necrotizing lymphadenitis associated with systemic lupus erythematosus
2
PubMed Central. Lymph nodes as gatekeepers of autoimmune diseases
3
PubMed Central. Systemic Lupus Erythematosus Lymphadenopathy Presenting as Kikuchi-Fujimoto Disease in an Adolescent
4
Egyptian Rheumatology and Rehabilitation. Generalized lymphadenopathy as an initial presentation of systemic lupus erythematosus: case report and review of the literature
5
PubMed. Autoimmune disease-associated lymphadenopathy with histological appearance of T-zone dysplasia with hyperplastic follicles
6
Rheumatology. Lymphadenopathy in the rheumatology practice: a pragmatic approach
7
PubMed Central. Lymph nodes as gatekeepers of autoimmune diseases – Section: Defective peripheral tolerance in the LN
8
PubMed. Lymphoma in Sjögren’s syndrome: no need for repetitive screening ultrasounds of the major salivary glands and neck in asymptomatic patients
9
PubMed Central. Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
10
Journal of Autoimmunity. Predictive markers of lymphomagenesis in Sjögren’s syndrome: From clinical data to molecular stratification
11
Egyptian Journal of Radiology and Nuclear Medicine. Mediastinal lymphadenopathy in sarcoidosis: Can diffusion MRI play a role in its evaluation?
12
PubMed Central. Endobronchial ultrasound diagnostic yield for sarcoidosis in hilar vs. mediastinal lymph nodes
13
PubMed Central. IgG4-Related Lymphadenopathy
14
PubMed Central. Autoimmune Lymphoproliferative Syndrome: An Overview
15
The American Journal of Pathology. Pathological Findings in Human Autoimmune Lymphoproliferative Syndrome
16
PubMed Central. Shifting cervical lymphadenopathy in Hashimoto’s disease
17
PubMed Central. Adult-Onset Still’s Disease With Extensive Lymphadenopathy Mimicking Lymphoproliferative Malignancy
18
PubMed Central. Idiopathic multicentric Castleman disease resembling autoimmune diseases: A case report
19
PubMed. Fatal Kikuchi-Fujimoto disease: the lupus connection
20
PubMed Central. Recurrence of Histiocytic Necrotizing Lymphadenitis in Children: A 10-year Multicenter Retrospective Study
21
PubMed Central. Lupus and Kikuchi-Fujimoto Disease: A Combination for Catastrophe
22
Medical Research Archives. Use of Pet/CT in different scenarios on rare and orphan diseases of autoimmune origin
23
PubMed Central. The Clinical Usefulness of (18)F-FDG PET/CT in Patients with Systemic Autoimmune Disease